June 6, 2007 — Results from an MRI substudy of the ongoing FRALYSE randomized trial, although not statistically significant for most end points, show positive trends that infusion of tissue ...

A new report details the case of a patient on the new experimental Alzheimer's drug, lecanemab, who died after experiencing numerous acute intracerebral hemorrhages during treatment with tissue ...

Administered slowly, low-dose infusions of tissue plasminogen activator (tPA) are associated with low mortality and high treatment success rates in patients with obstructive prosthetic valve ...

CHICAGO, IL—Low-dose coronary alteplase infused early after PCI does not reduce the likelihood of microvascular obstruction (MVO) in ST-segment elevation MI, the T-Time trial suggests. Colin Berry, MD ...

"What we saw in this preliminary study was that, after the initial hour-long infusion of tPA, if an intensive care need had not developed, the chance of needing ICU monitoring - including a ...

Thrombolytic therapy for ischemic stroke with tissue plasminogen activator (tPA) increases the risk of brain hemorrhage. In a Nature Medicine paper, Cheng et al. report that, in rodents, activated ...

The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots safely and more quickly than tPA alone, a new study suggests, based on results ...

Despite probable higher rates of recanalization with endovascular therapies, limited evidence exists to support the clinical benefits in patients with stroke who are unresponsive to standard ...

A new way of combining tissue plasminogen activator (tPA) along with drugs that target a protein called plasma kallikrein may improve treatment for stroke. Stroke caused by blood clots may involve the ...

A man in his late 30s is brought to the emergency department by medics after he called 911 for sudden onset of confusion and loss of coordination while driving. He denies any headaches or other ...

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a national specialty pharmacy benefit manager (SPBM) serving commercial, Medicare and Medicaid segments, is collaborating with Group & Pension ...

A study of patients with ischemic stroke suggests that many of those who receive prompt hospital treatment with "clot-busting" tissue plasminogen activator (tPA) therapy can avoid lengthy, restrictive ...